Page 4 - Us Trustee Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The Supreme Court is currently hearing oral arguments in a landmark bankruptcy case involving Purdue Pharma, the maker of OxyContin.

WASHINGTON — The Supreme Court justices seemed divided Monday over a fiercely contested bankruptcy settlement for Purdue Pharma that would funnel billions of dollars into addressing the opioid epidemic in exchange for shielding members of the wealthy Sackler family from related lawsuits. The U.S. Trustee Program, an office in the Justice Department, had challenged the deal for Purdue, the maker of the prescription painkiller OxyContin. It said the agreement violated federal law by guaranteeing s

The Supreme Court held its first day of oral arguments in a major bankruptcy case regarding an opioid crisis settlement for Purdue Pharma, the manufacturer of OxyContin. Justices questioned lawyers for roughly two hours regarding the deal, which would see Purdue release $6 billion to victims of the drug crisis while also granting immunity to

A ruling upholding a disputed provision in the settlement would finally start the flow of payments from the company and its owners — members of the billionaire Sackler family — to cities, states, tribes, and individuals to help them cope with the costs of the ongoing opioid crisis.

The justices will hear arguments on Monday about whether members of the wealthy Sackler family can be shielded from liability through a bankruptcy settlement.